39. Brady K, Corash L, Bhargava V: Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease. Arch Pathol Lab Med 121:1108-1111, 1997.
40. Shoenfeld Y, Gallant LA, Shaklai M, Livni E, Djaldetti M, Pinkhas J: Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106:388-391, 1982.
41. Brautbar A, Elstein D, Pines G, Abrahamov A, Zimran A: Effect of enzyme replacement therapy on gammopathies in Gaucher disease. Blood Cells Mol Dis 32:214-217, 2004.
42. Toth J, Kiss T, Varga S: [Multiple myeloma associated with rheumatoid arthritis]. Orv Hetil 113:2414-2415, 1972.
43. Perl AF: Multiple myeloma simulating rheumatoid arthritis. Can Med Assoc J 79:122-123, 1958.
44. Davis JS Jr, Weber FC, Bartfeld H: Conditions involving the hemopoietic system resulting in a pseudorheumatoid arthritis; similarity of multiple myeloma and rheumatoid arthritis. Ann Intern Med 47:10-17, 1957.
45. Buskila D, Sukenik S: [Multiple myeloma complicating rheumatoid arthritis]. Harefuah 115:319-321, 1988.
46. Hamano T, Ishikawa T, Yabe H, Nagai K, Nakayama S: [Rheumatoid arthritis terminating in multiple myeloma-a case report]. Rinsho Ketsueki 28:408-412, 1987.
47. Matsumori A, Nishiya K, Chijiwa T, et al.: [Two cases of rheumatoid arthritis associated with IgA-type multiple myeloma]. Ryumachi 40:26-31, 2000.
48. Usnarska-Zubkiewicz L, Czarnecka M, Wlodarczyk S, Nowak E: [Rheumatoid arthritis as a risk factor for development of multiple myeloma]. Pol Arch Med Wewn 97:253-259, 1997.
49. Eriksson M. Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur J Cancer 29A:259-263, 1993.
50. Rettig MB, Ma HJ, Vescio RA, et al.: Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276:1851-1854, 1997.
51. Tisdale JF, Stewart AK, Dickstein B, et al.: Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected. Blood 92:2681-2687, 1998.
52. Patel M, Mahlangu J, Patel J, et al.: Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and multiple myeloma in South Africa. Diagn Mol Pathol 10: 95-99, 2001.
53. Bouscary D, Dupin N, Fichelson S, et al.: Lack of evidence of an association between HHV-8 and multiple myeloma. Leukemia 12:1840-1841, 1998.
54. Rask C, Kelsen J, Olesen G, Nielsen JL, Obel N, Abildgaard N: Danish patients with untreated multiple myeloma do not harbour human herpesvirus 8. Br J Haematol 108:96-98, 2000.
55. MacKenzie J, Sheldon J, Morgan G, Cook G, Schulz TF, Jarrett RF: HHV-8 and multiple myeloma in the UK. Lancet 350:1144-1145, 1997.
56. Marcelin AG, Dupin N, Bouscary D, et al.: HHV-8 and multiple myeloma in France. Lancet 350:1144, 1997.
57. Cannon MJ, Flanders WD, Pellett PE: Occurrence of primary cancers in association with multiple myeloma and Kaposi's sarcoma in the United States, 1973-1995. Int J Cancer 85:453-456, 2000.
58. Voelkerding KV, Sandhaus LM, Kim HC, et al.: Plasma cell malignancy in the acquired immune deficiency syndrome. Association with Epstein-Barr virus. Am J Clin Pathol 92:222-228, 1989.
59. Karnad AB, Martin AW, Koh HK, Brauer MJ, Novich M, Wright J: Nonsecretory multiple myeloma in a 26-year-old man with acquired immunodeficiency syndrome, presenting with multiple extramedullary plasmacy-
tomas and osteolytic bone disease. Am J Hematol 32:305-310, 1989.
60. Barbanera M, Menicagli V: [Multiple myeloma in HIV infection]. Recenti Prog Med 81:663-665, 1990.
61. Konrad RJ, Kricka LJ, Goodman DB, Goldman J, Silberstein LE: Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. N Engl J Med 328:1817-1819, 1993.
62. Kumar S, Kumar D, Schnadig VJ, Selvanayagam P, Slaughter DP: Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol 102:633-639, 1994.
63. Yee TT, Murphy K, Johnson M, et al.: Multiple myeloma and human immunodeficiency virus-1 (HIV-1) infection. Am JHematol 66:123-125, 2001.
64. Pouli A, Lemessiou H, Rontogianni D, et al.: Multiple myeloma as the first manifestation of acquired immunodeficiency syndrome: a case report and review of the literature. Ann Hematol 80:557-560, 2001.
65. Lallemand F, Fritsch L, Cywiner-Golenzer C, Rozenbaum W: Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacy-tomas and spinal cord compression. J Am Acad Dermatol 39:506-508, 1998.
66. Talib SH, Singh J, Ranga S, Talib VH: Multiple myeloma complicating HIV-infection. A case report. Indian J Pathol Microbiol 40:413-416, 1997.
67. Faure I, Viallard JF, Mercie P, Bonnefoy M, Pellegrin JL, Leng B: Multiple myeloma in two HIV-infected patients. AIDS 13:1797-1799, 1999.
68. Elira Dokekias A, Moutschen M, Purhuence MF, Malanda
F, Moyikoua A: [Multiples's myeloma and HIV infection: report of 3 cases]. Rev Med Liege 59:95-97, 2004.
69. Montella M, Crispo A, Frigeri F, et al.: HCV and tumors correlated with immune system: a case-control study in an area of hyperendemicity. Leuk Res 2001;25:775-781.
70. Silvestri F, Barillari G, Fanin R, et al.: Risk of hepatitis C virus infection, Waldenstrom's macroglobulinemia, and monoclonal gammopathies. Blood 88:1125-1126, 1996.
71. Gharagozloo S, Khoshnoodi J, Shokri F: Hepatitis C virus infection in patients with essential mixed cryo-globulinemia, multiple myeloma and chronic lympho-cytic leukemia. Pathol Oncol Res 7:135-139, 2001.
72. Rabkin CS, Tess BH, Christianson RE, et al.: Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 99:4240-4242, 2002.
73. Bianco E, Marcucci F, Mele A, et al.: Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian multi-center case-control study. Haematologica 89:70-76, 2004.
74. Hausfater P, Cacoub P, Sterkers Y, et al.: Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 67:168-171, 2001.
75. Besson C, Gonin C, Brebion A, Delaunay C, Panelatti
G, Plumelle Y: Incidence of hematological malignancies in Martinique, French West Indies, overrepresenta-tion of multiple myeloma and adult T cell leukemia/lymphoma. Leukemia 15:828-831, 2001.
76. Cardis E, Gilbert ES, Carpenter L, et al.: Effects of low doses and low dose rates of external ionizing radiation:
cancer mortality among nuclear industry workers in three countries. Radiat Res 142:117-132, 1995.
77. Douglas AJ, Omar RZ, Smith PG: Cancer mortality and morbidity among workers at the Sellafield plant of British Nuclear Fuels. Br J Cancer 70:1232-1243, 1994.
78. Wing S, Richardson D, Wolf S, Mihlan G, Crawford-Brown D, Wood J: A case control study of multiple myeloma at four nuclear facilities. Ann Epidemiol 10:144-153, 2000.
79. Baysson H, Laurier D, Tirmarche M, Valenty M, Giraud JM: Epidemiological response to a suspected excess of cancer among a group of workers exposed to multiple radiological and chemical hazards. Occup Environ Med 57:188-194, 2000.
80. Lopez-Abente G, Aragones N, Pollan M, Ruiz M, Gandarillas A: Leukemia, lymphomas, and myeloma mortality in the vicinity of nuclear power plants and nuclear fuel facilities in Spain. Cancer Epidemiol Biomarkers Prev 8:925-934, 1999.
81. Agu VU, Christensen BL, Buffler PA: Geographic patterns of multiple myeloma: racial and industrial correlates, State of Texas, 1969-71. J Natl Cancer Inst 65:735-738, 1980.
82. Burmeister LF: Cancer mortality in Iowa farmers, 1971-78. J Natl Cancer Inst 66:461-464, 1981.
83. Cerhan JR, Cantor KP, Williamson K, Lynch CF, Torner JC, Burmeister LF: Cancer mortality among Iowa farmers: recent results, time trends, and lifestyle factors (United States). Cancer Causes Control 9:311-319, 1998.
84. Blair A: Cancer risks associated with agriculture: epi-demiologic evidence. Basic Life Sci 21:93-111, 1982.
85. Steineck G, Wiklund K: Multiple myeloma in Swedish agricultural workers. Int J Epidemiol 15:321-325, 1986.
86. Khuder SA, Mutgi AB: Meta-analyses of multiple myeloma and farming. Am JInd Med 32:510-516, 1997.
87. Assennato G, Ferri GM, Tria G, Porro A, Macinagrossa L, Ruggieri M: [Tumors of the hemolymphopoietic tract and employment in agriculture: a case-control study carried out in an epidemiologic area in southern Italy]. G Ital Med Lav 17:91-97, 1995.
88. Nanni O, Falcini F, Buiatti E, et al.: Multiple myeloma and work in agriculture: results of a case-control study in Forli, Italy. Cancer Causes Control 9:277-283, 1998.
89. Pukkala E, Notkola V: Cancer incidence among Finnish farmers, 1979-93. Cancer Causes Control 8:25-33, 1997.
90. Pahwa P, McDuffie HH, Dosman JA, et al.: Exposure to animals and selected risk factors among Canadian farm residents with Hodgkin's disease, multiple myeloma, or soft tissue sarcoma. J Occup Environ Med 45:857-868, 2003.
91. Monson RR, Nakano KK: Mortality among rubber workers. II: Other employees. Am J Epidemiol 103: 297-303, 1976.
92. Delzell E, Monson RR: Mortality among rubber workers. X: Reclaim workers. Am J Ind Med 7:307-313, 1985.
93. Matanoski G, Elliott E, Tao X, Francis M, Correa-Villasenor A, Santos-Burgoa C: Lymphohematopoietic cancers and butadiene and styrene exposure in synthetic rubber manufacture. Ann N Y Acad Sci 837:157-169, 1997.
94. Sorahan T, Parkes HG, Veys CA, Waterhouse JA, Straughan JK, Nutt A: Mortality in the British rubber industry 1946-85. Br J Ind Med 46:1-10, 1989.
95. Kogevinas M, Sala M, Boffetta P, Kazerouni N, Kromhout H, Hoar-Zahm S: Cancer risk in the rubber industry: a review of the recent epidemiological evidence. Occup Environ Med 55:1-12, 1998.
96. Sathiakumar N, Delzell E, Hovinga M, et al.: Mortality from cancer and other causes of death among synthetic rubber workers. Occup Environ Med 55:230-235, 1998.
97. Torres A, Giralt M, Raichs A: [Coexistence of chronic benzol contacts and multiple plasmacytoma. Presentation of 2 cases]. Sangre (Barc) 15:275-279, 1970.
98. Aksoy M: Malignancies due to occupational exposure to benzene. Haematologica 65:370-373, 1980.
99. Heineman EF, Olsen JH, Pottern LM, Gomez M, Raffn E, Blair A: Occupational risk factors for multiple myeloma among Danish men. Cancer Causes Control 3:555-568, 1992.
100. Pottern LM, Heineman EF, Olsen JH, Raffn E, Blair A: Multiple myeloma among Danish women: employment history and workplace exposures. Cancer Causes Control 3:427-432, 1992.
101. Bezabeh S, Engel A, Morris CB, Lamm SH: Does benzene cause multiple myeloma? An analysis of the published case-control literature. Environ Health Perspect 104(suppl 6):1393-1398, 1996.
102. Bergsagel DE, Wong O, Bergsagel PL, et al.: Benzene and multiple myeloma: appraisal of the scientific evidence. Blood 94:1174-1182, 1999.
103. Wong O, Raabe GK: Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. Regul Toxicol Pharmacol 26:188-199, 1997.
104. Sonoda T, Nagata Y, Mori M, Ishida T, Imai K: Meta-analysis of multiple myeloma and benzene exposure. J Epidemiol 11:249-254, 2001.
105. Lee WJ, Baris D, Jarvholm B, Silverman DT, Bergdahl IA, Blair A: Multiple myeloma and diesel and other occupational exposures in Swedish construction workers. Int J Cancer 107:134-138, 2003.
106. Bukowski JA, Huebner WW, Schnatter AR, Wojcik NC: An analysis of the risk of B-lymphocyte malignancies in industrial cohorts. J Toxicol Environ Health A 66: 581-597, 2003.
107. Golden AL, Markowitz SB, Landrigan PJ: The risk of cancer in firefighters. Occup Med 10:803-820, 1995.
108. Eriksson M, Karlsson M: Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br J Ind Med 49:95-103, 1992.
109. Nandakumar A, Armstrong BK, de Klerk NH: Multiple myeloma in Western Australia: a case-control study in relation to occupation, father's occupation, socioeconomic status and country of birth. Int J Cancer 37: 223-226, 1986.
110. Flodin U, Fredriksson M, Persson B: Multiple myeloma and engine exhausts, fresh wood, and creosote: a case-referent study. Am J Ind Med 12:519-529, 1987.
111. La Vecchia C, Negri E, D'Avanzo B, Franceschi S: Occupation and lymphoid neoplasms. Br J Cancer 60:385-388, 1989.
112. Demers PA, Boffetta P, Kogevinas M, et al.: Pooled reanalysis of cancer mortality among five cohorts of workers in wood-related industries. Scand J Work Environ Health 21:179-190, 1995.
113. Fritschi L, Siemiatycki J: Lymphoma, myeloma and occupation: results of a case-control study. Int J Cancer 67:498-503, 1996.
114. Fu H, Demers PA, Costantini AS, et al.: Cancer mortality among shoe manufacturing workers: an analysis of two cohorts. Occup Environ Med 53:394-398, 1996.
115. Wartenberg D, Reyner D, Scott CS: Trichloroethylene and cancer: epidemiologic evidence. Environ Health Perspect 108(suppl 2):161-176, 2000.
116. Costantini AS, Miligi L, Kriebel D, et al.: A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology 12:78-87, 2001.
117. Gallagher RP, Threlfall WJ: Cancer mortality in metal workers. Can Med Assoc J 129:1191-1194, 1983.
118. Morris PD, Koepsell TD, Daling JR, et al.: Toxic substance exposure and multiple myeloma: a case-control study. J Natl Cancer Inst 76:987-994, 1986.
119. McWhorter WP, Schatzkin AG, Horm JW, Brown CC: Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 63:982-987, 1989.
120. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J: Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet 351:934-939, 1998.
121. Clayton LA, Byrd WM: The African-American cancer crisis. Part I: The problem. J Health Care Poor Underserved 4:83-101, 1993.
122. Vlajinac HD, Pekmezovic TD, Adanja BJ, et al.: case-control study of multiple myeloma with special reference to diet as risk factor. Neoplasma 50:79-83, 2003.
123. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr: Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15:35-43, 2004.
124. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638, 2003.
125. Mills PK, Newell GR, Beeson WL, Fraser GE, Phillips RL: History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. J Natl Cancer Inst 82:1832-1836, 1990.
126. Heineman EF, Zahm SH, McLaughlin JK, Vaught JB, Hrubec Z: A prospective study of tobacco use and multiple myeloma: evidence against an association. Cancer Causes Control 3:31-36, 1992.
127. Brownson RC: Cigarette smoking and risk of myeloma. J Natl Cancer Inst 83:1036-1037, 1991.
128. Brown LM, Everett GD, Gibson R, Burmeister LF, Schuman LM, Blair A: Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control 3:49-55, 1992.
129. Friedman GD: Cigarette smoking, leukemia, and multiple myeloma. Ann Epidemiol 3:425-428, 1993.
130. Adami J, Nyren O, Bergstrom R, et al.: Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 9:49-56, 1998.
131. Stagnaro E, Ramazzotti V, Crosignani P, et al.: Smoking and hematolymphopoietic malignancies. Cancer Causes Control 12:325-334, 2001.
132. Brown LM, Everett GD, Burmeister LF, Blair A: Hair dye use and multiple myeloma in white men. Am J Public Health 82:1673-1674, 1992.
133. Zahm SH, Weisenburger DD, Babbitt PA, Saal RC, Vaught JB, Blair A: Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health 82:990-997, 1992.
134. Herrinton LJ, Weiss NS, Koepsell TD, et al.: Exposure to hair-coloring products and the risk of multiple myeloma. Am J Public Health 84:1142-1144, 1994.
135. Thun MJ, Altekruse SF, Namboodiri MM, Calle EE, Myers DG, Heath CW Jr: Hair dye use and risk of fatal cancers in U.S. women. J Natl Cancer Inst 86:210-215, 1994.
136. Colditz GA: Hair dye and cancer: reassuring evidence of no association. J Natl Cancer Inst 86:164-165, 1994.
137. Grodstein F, Hennekens CH, Colditz GA, Hunter DJ, Stampfer MJ: A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst 86:1466-1470, 1994.
138. Altekruse SF, Henley SJ, Thun MJ: Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 10:617-625, 1999.
139. Hartge P: Hair dyes, cancer, and epidemiology. Cancer Invest 18:408, 2000.
140. Berlin SO, Odeberg H, Weingart L: Familial occurrence of M-components. Acta Med Scand 183:347-350, 1968.
141. Boga M, Jako J, Doman J, Magyar E, Konyar E: Familial myeloma. Folia Haematol Int Mag Klin Morphol Blutforsch 100:201-212, 1973.
142. Maldonado JE, Kyle RA: Familial myeloma. Report of eight families and a study of serum proteins in their relatives. Am J Med 57:875-884, 1974.
143. Law MI: Familial occurrence of multiple myeloma. South Med J 69:46-48, 1976.
144. Zawadzki ZA, Aizawa Y, Kraj MA, Haradin AR, Fisher B: Familial immunopathies: report of nine families and survey of literature. Cancer 40:2094-2101, 1977.
145. Youinou P, le Goff P, Saleun JP, et al.: Familial occurrence of monoclonal gammapathies. Biomedicine 28:226-232, 1978.
146. Deshpande HA, Hu XP, Marino P, Jan NA, Wiernik PH: Anticipation in familial plasma cell dyscrasias. Br J Haematol 103:696-703, 1998.
147. Shoenfeld Y, Berliner S, Shaklai M, Gallant LA, Pinkhas J: Familial multiple myeloma. A review of thirty-seven families. Postgrad Med J 58:12-16, 1982.
148. Bourguet CC, Grufferman S, Delzell E, DeLong ER, Cohen HJ: Multiple myeloma and family history of cancer. A case-control study. Cancer 56:2133-2139, 1985.
149. Loth TS, Perrotta AL, Lima J, Whiteaker RS, Robinson A: Genetic aspects of familial multiple myeloma. Mil Med 156:430-433, 1991.
150. Ogawa M, Wurster DH, McIntyre OR: Multiple myeloma in one of a pair of monozygotic twins. Acta Haematol 44:295-304, 1970.
151. Snowden JA, Greaves M: IgA lambda myeloma presenting concurrently in identical twins with subsequent transformation to 'aggressive phase' in one. Clin Lab Haematol 17:95-96, 1995.
152. Judson IR, Wiltshaw E, Newland AC: Multiple myeloma in a pair of monozygotic twins: the first reported case. Br J Haematol 60:551-554, 1985.
153. Hemminki K, Vaittinen P: National database of familial cancer in Sweden. Genet Epidemiol 15:225-236, 1998.
154. Brown LM, Linet MS, Greenberg RS, et al.: Multiple myeloma and family history of cancer among blacks and whites in the U.S. Cancer 85:2385-2390, 1999.
155. Grosbois B, Jego P, Attal M, et al.: Familial multiple myeloma: report of fifteen families. Br J Haematol 105:768-770, 1999.
156. Lynch HT, Sanger WG, Pirruccello S, Quinn-Laquer B, Weisenburger DD: Familial MM: a family study and review of the literature. J Natl Cancer Inst 93:1479-1483, 2001.
157. Hemminki K: Re: familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 94:462-463, 2002; author reply: 463.
158. Sobol H, Vey N, Sauvan R, Philip N, Noguchi T, Eisinger F: Re: familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 94:461-462, 2002; author reply: 463.
159. Nakayama S, Kitajima K, Ueno K, Hoshino T: [Multiple myeloma in spouses-with special reference to BHC as a possible cause (author's trans)]. Rinsho Ketsueki 21:73-79, 1980.
160. Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A: Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica 89:628-629, 2004.
161. Davies FE, Dring AM, Li C, et al.: Insights into the multistep transformation of MGUS to myeloma using microar-ray expression analysis. Blood 102:4504-4511, 2003.
162. Munshi NC, Hideshima T, Carrasco D, et al.: Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood 103:1799-1806, 2004.
This page intentionally left blank
Was this article helpful?